Fluorouracil

Generic Name
Fluorouracil
Brand Names
Actikerall, Carac, Efudex, Fluoroplex, Tolak
Drug Type
Small Molecule
Chemical Formula
C4H3FN2O2
CAS Number
51-21-8
Unique Ingredient Identifier
U3P01618RT
Background

A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the thymidylate synthetase conversion of deoxyuridylic acid to thymidylic acid.

Indication

For the topical treatment of multiple actinic or solar keratoses. In the 5% strength it is also useful in the treatment of superficial basal cell carcinomas when conventional methods are impractical, such as with multiple lesions or difficult treatment sites. Fluorouracil injection is indicated in the palliative management of some types of cancer, including ...

Associated Conditions
Actinic Keratosis (AK), Breast Cancer, Colon Cancer, Gastric Cancer, Pancreatic Cancer, Rectal Cancer, Superficial Basal Cell Carcinoma, Verruca (Warts), Hyperkeratotic actinic keratosis
Associated Therapies
-

Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Solid Tumors

First Posted Date
2003-01-27
Last Posted Date
2013-06-04
Lead Sponsor
National Cancer Institute (NCI)
Target Recruit Count
77
Registration Number
NCT00042874
Locations
🇺🇸

Memorial Sloan Kettering Cancer Center, New York, New York, United States

High-Dose Fluorouracil With or Without Leucovorin Compared With Standard Fluorouracil Plus Leucovorin Following Surgery in Treating Patients With Stage III Colon Cancer

Phase 3
Completed
Conditions
First Posted Date
2003-01-27
Last Posted Date
2013-11-06
Lead Sponsor
Robert Roessle Klinik
Registration Number
NCT00004150
Locations
🇧🇪

Universitair Ziekenhuis Antwerpen, Edegem, Belgium

🇫🇷

CHR de Besancon - Hopital Jean Minjoz, Besancon, France

🇫🇷

Centre Hospitalier de Bourgoin - Jallieu, Bourgoin-Jallieu, France

and more 81 locations

Combination Chemotherapy in Treating Patients With Colorectal Cancer

Phase 2
Completed
Conditions
First Posted Date
2003-01-27
Last Posted Date
2012-07-13
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Registration Number
NCT00039208
Locations
🇫🇷

Hopital Saint-Louis, Paris, France

🇫🇷

Centre de Lutte Contre le Cancer Georges-Francois Leclerc, Dijon, France

🇫🇷

Centre Hospital Regional Universitaire de Limoges, Limoges, France

and more 17 locations

Vinorelbine Plus Fluorouracil in Treating Women With Metastatic Breast Cancer

Not Applicable
Completed
Conditions
First Posted Date
2003-01-27
Last Posted Date
2012-07-02
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
80
Registration Number
NCT00003730
Locations
🇧🇪

VZW Monica Campus Eeuwfeestkliniek, Antwerpen, Belgium

🇬🇷

University Hospital of Heraklion, Iraklion (Heraklion), Crete, Greece

🇮🇹

Istituto per la Ricerca e Cura del Cancro, Candiolo (Turin), Italy

and more 14 locations

Fluorouracil With or Without Cisplatin in Treating Patients With Advanced or Metastatic Cancer of the Pancreas

Phase 3
Completed
Conditions
First Posted Date
2003-01-27
Last Posted Date
2012-07-02
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
200
Registration Number
NCT00003029
Locations
🇫🇷

Centre Hospitalier de la Cote Basque, Bayonne, France

🇫🇷

Hopital Perpetuel Secours, Levallois-Perret, France

🇧🇪

Les Cliniques Saint-Joseph ASBL, Liege, Belgium

and more 16 locations

Triacetyluridine and Fluorouracil Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced, or Metastatic Pancreatic Cancer

First Posted Date
2003-01-27
Last Posted Date
2012-06-28
Lead Sponsor
Wellstat Therapeutics
Target Recruit Count
250
Registration Number
NCT00024427
Locations
🇺🇸

University of Miami Sylvester Comprehensive Cancer Center, Miami, Florida, United States

🇺🇸

Cancer Center at Greater Baltimore Medical Center, Baltimore, Maryland, United States

🇺🇸

Fox Chase - Temple Cancer Center, Philadelphia, Pennsylvania, United States

and more 26 locations

Whole Body Hyperthermia Combined With Chemotherapy in Treating Patients With Metastatic Breast, Ovarian, Endometrial, or Cervical Cancer

First Posted Date
2003-01-27
Last Posted Date
2009-04-30
Lead Sponsor
The University of Texas Health Science Center, Houston
Target Recruit Count
34
Registration Number
NCT00003135
Locations
🇺🇸

University of Texas Health Science Center at Houston, Houston, Texas, United States

Fluorouracil Plus Radiation Therapy Following Surgery in Treating Patients With Pancreatic Cancer

Phase 2
Conditions
First Posted Date
2003-01-27
Last Posted Date
2009-02-09
Lead Sponsor
GERCOR - Multidisciplinary Oncology Cooperative Group
Registration Number
NCT00010062
Locations
🇫🇷

Hopital Claude Gallien, Quincy Sous Senart, France

🇫🇷

Hopital Laennec, Paris, France

🇫🇷

Polyclinique Jeanne d'Arc - service de Radiotherapie Oncologie, Gien, France

and more 26 locations

Combination Chemotherapy in Treating Women With Resected Breast Cancer

Phase 2
Conditions
First Posted Date
2003-01-27
Last Posted Date
2009-02-09
Lead Sponsor
Institute of Cancer Research, United Kingdom
Registration Number
NCT00033683
Locations
🇬🇧

St. Georges Hospital Medical School, London, England, United Kingdom

🇬🇧

Huddersfield Royal Infirmary, Huddersfield, West Yorks, England, United Kingdom

🇬🇧

Leicester Royal Infirmary, Leicester, England, United Kingdom

and more 66 locations

Combination Chemotherapy Combined With Radiation Therapy in Treating Patients Who Have Stage II or Stage III Cancer of the Esophagus

Phase 1
Conditions
First Posted Date
2003-01-27
Last Posted Date
2009-02-09
Lead Sponsor
GERCOR - Multidisciplinary Oncology Cooperative Group
Registration Number
NCT00008047
Locations
🇫🇷

Centre Jean Bernard, Le Mans, France

🇫🇷

Clinique Saint - Jean, Cagne-sur-Mer, France

🇫🇷

Hopital Andre Mignot, Le Chesnay, France

and more 11 locations
© Copyright 2024. All Rights Reserved by MedPath